Monday, March 26, 2001
Affymetrix Inc. finished clearing away the underbrush of its patent
dispute with Oxford Gene Technology Ltd., announcing late Friday that it had settled all
pending litigation with the U.K. company. The companies dropped lawsuits in the U.S. and
U.K. as well as patent interference proceedings in Europe, leaving AFFX with a license to
Oxford Gene's technology.
Oxford Gene (Oxford, U.K.) had been claiming that its array
intellectual property, including U.S. Patent No. 5,700,637, were infringed by AFFX's DNA